LAVA THERAPEUTICS NV (LVTX)
NL0015000AG6 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 33.91M | 90.40M | 14.40M | 14.60M | 7.20M | |||
| Marketable Securities | 61.67M | 42.50M | 118.80M | 1.20M | 100.00K | |||
| Receivables | 1.70M | 3.30M | 700.00K | 1.50M | 200.00K | |||
| Other Current Assets | 1.63M | 4.40M | 2.60M | 900.00K | 100.00K | |||
| Total Current Assets | 98.90M | 140.50M | 136.50M | 18.20M | 7.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 2.49M | 2.10M | 1.90M | 1.50M | 1.10M | |||
| Other Non-Current Assets | 319.00K | 800.00K | 800.00K | 800.00K | 0.00 | |||
| Total Non-Current Assets | 2.81M | 2.90M | 2.70M | 2.30M | 1.20M | |||
| TOTAL ASSETS | 101.71M | 143.40M | 139.20M | 20.50M | 8.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 5.28M | 4.60M | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 440.00K | 400.00K | 300.00K | 200.00K | 300.00K | |||
| Accrued Expenses | 4.29M | 7.80M | 1.60M | 1.30M | 800.00K | |||
| Accounts Payable | 4.45M | 4.00M | 2.60M | 900.00K | 400.00K | |||
| Other Current Liabilities | 482.00K | 5.10M | 6.90M | 4.90M | 0.00 | |||
| Total Current Liabilities | 14.94M | 22.00M | 11.20M | 7.30M | 1.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 591.00K | 400.00K | 4.60M | 3.90M | 1.50M | |||
| Other Non-Current Liabilities | 35.00M | 35.00M | 5.00M | 1.70M | 0.00 | |||
| Total Non-Current Liabilities | 35.59M | 35.40M | 9.70M | 5.60M | 1.60M | |||
| TOTAL LIABILITIES | 50.53M | 57.40M | 20.90M | 12.90M | 3.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -136.06M | -99.10M | -73.50M | -32.50M | -13.30M | |||
| Additional Paid In Capital | 194.42M | 194.40M | 192.30M | 41.10M | 19.10M | |||
| Common Shares | 3.71M | 3.70M | 3.70M | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -10.90M | -13.00M | -4.00M | -1.00M | 0.00 | |||
| Shares Outstanding | 26.29M | 26.30M | 25.80M | 25.40M | 25.40M | |||
| Tangible Book Value per Share | 1.95 | 3.27 | 4.59 | 0.30 | 0.23 | |||
| Total Shareholders' Equity | 51.18M | 86.00M | 118.40M | 7.60M | 5.80M | |||
| TOTAL LIABILITIES AND EQUITY | 101.71M | 143.40M | 139.20M | 20.50M | 8.80M | |||
| Statistics | ||||||||
| Debt/Equity | 0.11 | 0.06 | 0.04 | 0.51 | 0.26 | |||
| Current Ratio | 6.62 | 6.39 | 12.19 | 2.49 | 5.43 | |||
| Return On Assets (ROA) | -41.27% | -22.25% | -32.58% | -75.66% | -110.11% | |||
| Return On Equity (ROE) | -82.02% | -37.10% | -38.30% | -204.08% | -167.07% | |||
All data in USD